The imperative of overcoming barriers to the conduct of large, simple trials.
Publication
, Journal Article
Eapen, ZJ; Lauer, MS; Temple, RJ
Published in: JAMA
April 9, 2014
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 9, 2014
Volume
311
Issue
14
Start / End Page
1397 / 1398
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Randomized Controlled Trials as Topic
- Precision Medicine
- Humans
- General & Internal Medicine
- Drug Evaluation
- Data Collection
- Biomarkers
- 42 Health sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Eapen, Z. J., Lauer, M. S., & Temple, R. J. (2014). The imperative of overcoming barriers to the conduct of large, simple trials. JAMA, 311(14), 1397–1398. https://doi.org/10.1001/jama.2014.1030
Eapen, Zubin J., Michael S. Lauer, and Robert J. Temple. “The imperative of overcoming barriers to the conduct of large, simple trials.” JAMA 311, no. 14 (April 9, 2014): 1397–98. https://doi.org/10.1001/jama.2014.1030.
Eapen ZJ, Lauer MS, Temple RJ. The imperative of overcoming barriers to the conduct of large, simple trials. JAMA. 2014 Apr 9;311(14):1397–8.
Eapen, Zubin J., et al. “The imperative of overcoming barriers to the conduct of large, simple trials.” JAMA, vol. 311, no. 14, Apr. 2014, pp. 1397–98. Pubmed, doi:10.1001/jama.2014.1030.
Eapen ZJ, Lauer MS, Temple RJ. The imperative of overcoming barriers to the conduct of large, simple trials. JAMA. 2014 Apr 9;311(14):1397–1398.
Published In
JAMA
DOI
EISSN
1538-3598
Publication Date
April 9, 2014
Volume
311
Issue
14
Start / End Page
1397 / 1398
Location
United States
Related Subject Headings
- United States Food and Drug Administration
- United States
- Randomized Controlled Trials as Topic
- Precision Medicine
- Humans
- General & Internal Medicine
- Drug Evaluation
- Data Collection
- Biomarkers
- 42 Health sciences